US 12,290,667 B2
Therapy assist information and/or tracking device and related methods and systems
John Sjolund, Los Altos, CA (US); Ambika Srinath, San Francisco, CA (US); Andrew Bochenko, Redwood City, CA (US); George Crothall, Oceanside, CA (US); Bryan Mazlish, Palo Alto, CA (US); Lane Desborough, Thousand Oaks, CA (US); Jennifer Martin Block, Menlo Park, CA (US); Sarah Matarese, San Jose, CA (US); and Linda Mackowiak, Cazenovia, NY (US)
Assigned to Bigfoot Biomedical, Inc., Milpitas, CA (US)
Filed by Bigfoot Biomedical, Inc., Milpitas, CA (US)
Filed on Jun. 14, 2022, as Appl. No. 17/806,881.
Application 17/806,881 is a continuation of application No. 17/303,748, filed on Jun. 7, 2021, granted, now 11,771,835.
Application 17/303,748 is a continuation of application No. 16/218,026, filed on Dec. 12, 2018, granted, now 11,027,073, issued on Jun. 8, 2021.
Claims priority of provisional application 62/682,872, filed on Jun. 9, 2018.
Claims priority of provisional application 62/628,808, filed on Feb. 9, 2018.
Claims priority of provisional application 62/597,868, filed on Dec. 12, 2017.
Claims priority of provisional application 62/597,809, filed on Dec. 12, 2017.
Prior Publication US 2022/0305207 A1, Sep. 29, 2022
Int. Cl. A61B 5/00 (2006.01); A61B 5/145 (2006.01); A61K 38/28 (2006.01); A61M 5/00 (2006.01); A61M 5/168 (2006.01); A61M 5/20 (2006.01); A61M 5/315 (2006.01); A61M 5/32 (2006.01); G16H 20/13 (2018.01); G16H 20/17 (2018.01); G16H 20/60 (2018.01); G16H 40/63 (2018.01); G16H 40/67 (2018.01); G16H 50/20 (2018.01); G16H 50/30 (2018.01); A61M 5/142 (2006.01); A61M 5/24 (2006.01); A61M 5/31 (2006.01)
CPC A61M 5/31546 (2013.01) [A61B 5/0004 (2013.01); A61B 5/14532 (2013.01); A61B 5/4836 (2013.01); A61B 5/4839 (2013.01); A61B 5/7405 (2013.01); A61B 5/7435 (2013.01); A61B 5/7455 (2013.01); A61B 5/746 (2013.01); A61K 38/28 (2013.01); A61M 5/003 (2013.01); A61M 5/168 (2013.01); A61M 5/20 (2013.01); A61M 5/31525 (2013.01); A61M 5/3202 (2013.01); G16H 20/13 (2018.01); G16H 20/17 (2018.01); G16H 20/60 (2018.01); G16H 40/63 (2018.01); G16H 40/67 (2018.01); G16H 50/20 (2018.01); G16H 50/30 (2018.01); A61B 5/14546 (2013.01); A61B 5/681 (2013.01); A61M 2005/14208 (2013.01); A61M 2005/2006 (2013.01); A61M 5/24 (2013.01); A61M 2005/3125 (2013.01); A61M 2205/18 (2013.01); A61M 2205/3306 (2013.01); A61M 2205/3561 (2013.01); A61M 2205/3584 (2013.01); A61M 2205/502 (2013.01); A61M 2205/505 (2013.01); A61M 2205/581 (2013.01); A61M 2205/582 (2013.01); A61M 2205/583 (2013.01); A61M 2209/06 (2013.01); A61M 2230/201 (2013.01)] 62 Claims
OG exemplary drawing
 
1. An accessory for an insulin pen, the accessory comprising:
at least one user interface to display a time since at least one of a capping or decapping of the accessory via one or more indicators; and
a controller comprising:
at least one processor; and
at least one non-transitory computer-readable storage medium storing instructions thereon that, when executed by the at least one processor, cause the controller to:
detect at least one of a capping or a decapping of the accessory from an insulin pen; and
responsive to the accessory being capped on or uncapped from the insulin pen, determine a missed dose.